A mindfulness-based therapy in which individuals learn to repeat personalized mantras to relax their...

It is well known that some patients with depression will fail to respond to medications, but clinici...

Although cognitive-behavioral therapy for insomnia (CBT-I) is recommended as a first-line treatment ...

The Food and Drug Administration on Tuesday announced that a new warning of the serious adverse outc...

A study published today in JAMA Internal Medicine suggests that phone-based cognitive-behavioral the...

A form of cognitive-behavioral therapy especially developed to treat insomnia (CBT-I) was found to b...

A new surveillance study has found that benzodiazepine usage increases with age, with nearly 9 perce...

Last week, the Food and Drug Administration (FDA) approved Belsomra (suvoraxant) to treat individual...

The Food and Drug Administration has advised Merck Pharmaceuticals that suvorexant, the company’s in...